(VIANEWS) - First Interstate BancSystem (FIBK), Business First Bancshares (BFST), StoneX Group (SNEX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. First Interstate BancSystem (FIBK)
70.1% sales growth and 3.99% return on equity
First Interstate BancSystem, Inc. is the bank holding company of First Interstate Bank. It provides a range of services and products in banking across the United States.
First Interstate BancSystem's sales growth this year is anticipated to be 68% and 13.1% for next year.
Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 650.9M for the twelve trailing months.
Volume
Today's last reported volume for First Interstate BancSystem is 313985 which is 60.84% below its average volume of 801942.
First Interstate BancSystem's sales growth for the next quarter is 70.1%. The company's growth estimates for the present quarter and the next is a negative 29% and 3.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.99%.
Volatility
First Interstate BancSystem's last day, last week, and last month's current intraday variation average was 0.51%, 1.73%, and 1.75%, respectively.
First Interstate BancSystem's highest amplitude of average volatility was 3.49% (day), 2.65% (last week), and 3.13% (last month), respectively.
First Interstate BancSystem's Stock Yearly Top and Bottom Value
First Interstate BancSystem's stock is valued at $33.61 at 20:22 EST, way under its 52-week high of $47.87 and above its 52-week low of $32.40.
First Interstate BancSystem's Moving Average
First Interstate BancSystem's value is under its 50-day moving average of $35.68 and way under its 200-day moving average of $39.83.2. Business First Bancshares (BFST)
27.9% sales growth and 11.11% return on equity
Business First Bancshares, Inc. is the bank holding company of b1BANK, which provides a variety of banking products and services.
Business First Bancshares's sales growth this year is expected to be 12.8% and 14.6% for next year.
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 184.58M for the twelve trailing months.
Volume
Today's last reported volume for Business First Bancshares is 32066 which is 3.91% below its average volume of 33371.
Business First Bancshares's sales growth for the next quarter is 27.9%. The company's growth estimates for the current quarter and the next is a negative 33.3% and 26%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.11%.
Volatility
Business First Bancshares's last day, last week, and last month's current intraday variation average was 1.67%, 1.10%, and 1.65%, respectively.
Business First Bancshares's highest amplitude of average volatility was 1.71% (day), 2.60% (last week), and 3.23% (last month), respectively.
Business First Bancshares's Stock Yearly Top and Bottom Value
Business First Bancshares's stock is valued at $21.92 at 20:22 EST, way under its 52-week high of $29.50 and higher than its 52-week low of $20.84.
Business First Bancshares's Moving Average
Business First Bancshares's worth is under its 50-day moving average of $23.04 and way below its 200-day moving average of $25.36.3. StoneX Group (SNEX)
18.3% sales growth and 15.81% return on equity
StoneX Group Inc. is a financial network connecting companies, investors, traders and organizations to the global market.
StoneX Group's sales growth this year is expected to be 16.5% and a negative 0.5% for next year.
Year-on-year quarterly revenue growth grew by 55.1%, now sitting on 47.53B for the twelve trailing months.
Volume
Today's last reported volume for StoneX Group is 31874 which is 50.45% below its average volume of 64338.
StoneX Group's sales growth is a negative 0% for the ongoing quarter and 18.3% for the next. The company's growth estimates for the current quarter and the next is a negative 15% and 173.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.81%.
Volatility
StoneX Group's last day, last week, and last month's current intraday variation average was 1.70%, 0.88%, and 1.88%, respectively.
StoneX Group's highest amplitude of average volatility was 1.36% (day), 2.38% (last week), and 3.30% (last month), respectively.
StoneX Group's Stock Yearly Top and Bottom Value
StoneX Group's stock is valued at $74.94 at 20:22 EST, under its 52-week high of $77.50 and way higher than its 52-week low of $52.31.
StoneX Group's Moving Average
StoneX Group's value is higher than its 50-day moving average of $72.60 and higher than its 200-day moving average of $68.67.4. Surgery Partners (SGRY)
17.4% sales growth and 3.6% return on equity
Surgery Partners, Inc., via its subsidiaries, operates a network in America of surgical facilities as well as ancillary services.
Surgery Partners's sales growth this year is expected to be 15.1% and 11.6% for next year.
Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 2.23B for the twelve trailing months.
Volume
Today's last reported volume for Surgery Partners is 675101 which is 39.84% above its average volume of 482761.
Surgery Partners's sales growth for the next quarter is 17.4%. The company's growth estimates for the current quarter and the next is a negative 0% and 260%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.6%.
Volatility
Surgery Partners's last day, last week, and last month's current intraday variation average was 1.18%, 1.00%, and 4.28%, respectively.
Surgery Partners's highest amplitude of average volatility was 4.64% (day), 5.49% (last week), and 7.68% (last month), respectively.
Surgery Partners's Stock Yearly Top and Bottom Value
Surgery Partners's stock is valued at $40.24 at 20:22 EST, way under its 52-week high of $69.58 and higher than its 52-week low of $36.96.
Surgery Partners's Moving Average
Surgery Partners's value is way under its 50-day moving average of $50.43 and way below its 200-day moving average of $47.97.5. Washington Federal (WAFD)
14.3% sales growth and 8.81% return on equity
Washington Federal, Inc. is the bank holding firm for Washington Federal Bank, National Association. It provides banking services, including insurance, lending, deposit, and depository, in the United States.
Washington Federal's sales growth this year is anticipated to be 11.4% and 12.7% for next year.
Year-on-year quarterly revenue growth declined by 0.7%, now sitting on 598.84M for the twelve trailing months.
Volume
Today's last reported volume for Washington Federal is 388620 which is 5.17% below its average volume of 409832.
Washington Federal's sales growth for the next quarter is 14.3%. The company's growth estimates for the present quarter and the next is 26.2% and 18.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.81%.
Volatility
Washington Federal's last day, last week, and last month's current intraday variation average was 0.85%, 0.98%, and 1.30%, respectively.
Washington Federal's highest amplitude of average volatility was 2.20% (day), 2.29% (last week), and 2.58% (last month), respectively.
Washington Federal's Stock Yearly Top and Bottom Value
Washington Federal's stock is valued at $31.03 at 20:22 EST, way below its 52-week high of $38.06 and above its 52-week low of $29.01.
Washington Federal's Moving Average
Washington Federal's value is under its 50-day moving average of $32.08 and under its 200-day moving average of $33.86.6. Allegion plc Ordinary Shares (ALLE)
13.3% sales growth and 63.44% return on equity
Allegion plc produces and sells electronic and mechanical security solutions and products worldwide.
Allegion plc Ordinary Shares's sales growth this year is expected to be 8.7% and 8.3% for next year.
Year-on-year quarterly revenue growth grew by 4.2%, now sitting on 2.9B for the twelve trailing months.
Volume
Today's last reported volume for Allegion plc Ordinary Shares is 148143 which is 80.16% below its average volume of 746795.
Allegion plc Ordinary Shares's sales growth is a negative 0% for the current quarter and 13.3% for the next. The company's growth estimates for the ongoing quarter and the next is 1.5% and 3.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 63.44%.
Volatility
Allegion plc Ordinary Shares's last day, last week, and last month's current intraday variation average was 1.69%, 1.44%, and 1.60%, respectively.
Allegion plc Ordinary Shares's highest amplitude of average volatility was 2.12% (day), 2.42% (last week), and 3.10% (last month), respectively.
Allegion plc Ordinary Shares's Stock Yearly Top and Bottom Value
Allegion plc Ordinary Shares's stock is valued at $110.75 at 20:22 EST, way below its 52-week high of $148.70 and above its 52-week low of $105.06.
Allegion plc Ordinary Shares's Moving Average
Allegion plc Ordinary Shares's worth is below its 50-day moving average of $111.72 and way under its 200-day moving average of $124.61.7. Organogenesis Holdings (ORGO)
12.9% sales growth and 49.45% return on equity
Organogenesis Holdings Inc. is a company that develops and manufactures regenerative medicine solutions in the United States.
Organogenesis Holdings 's sales growth this year is anticipated to be 6.2% and 11.1% for next year.
Year-on-year quarterly revenue growth grew by 20.4%, now sitting on 468.06M for the twelve trailing months.
Volume
Today's last reported volume for Organogenesis Holdings is 738338 which is 34.72% below its average volume of 1131170.
Organogenesis Holdings 's sales growth for the next quarter is 12.9%. The company's growth estimates for the present quarter and the next is a negative 40% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 49.45%.
Volatility
Organogenesis Holdings 's last day, last week, and last month's current intraday variation average was 6.42%, 3.15%, and 4.84%, respectively.
Organogenesis Holdings 's highest amplitude of average volatility was 6.58% (day), 5.70% (last week), and 8.31% (last month), respectively.
Organogenesis Holdings 's Stock Yearly Top and Bottom Value
Organogenesis Holdings 's stock is valued at $5.97 at 20:22 EST, way below its 52-week high of $18.28 and way higher than its 52-week low of $5.30.
Organogenesis Holdings 's Moving Average
Organogenesis Holdings 's value is way below its 50-day moving average of $6.85 and way under its 200-day moving average of $9.78.8. Cognizant Technology Solutions (CTSH)
8.1% sales growth and 18.72% return on equity
Cognizant Technology Solutions Corporation is a company that provides professional services, including technology and consulting services.
Cognizant Technology Solutions's sales growth this year is anticipated to be 8.3% and 8.8% for next year.
Year-on-year quarterly revenue growth grew by 14.2%, now sitting on 18.51B for the twelve trailing months.
Volume
Today's last reported volume for Cognizant Technology Solutions is 1561830 which is 50.33% below its average volume of 3144550.
Cognizant Technology Solutions's sales growth is a negative 0% for the ongoing quarter and 8.1% for the next. The company's growth estimates for the ongoing quarter and the next is 9.1% and 10.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.72%.
Volatility
Cognizant Technology Solutions's last day, last week, and last month's current intraday variation average was 1.90%, 1.29%, and 1.61%, respectively.
Cognizant Technology Solutions's highest amplitude of average volatility was 1.68% (day), 1.97% (last week), and 2.82% (last month), respectively.
Cognizant Technology Solutions's Stock Yearly Top and Bottom Value
Cognizant Technology Solutions's stock is valued at $73.39 at 20:22 EST, way below its 52-week high of $93.47 and way above its 52-week low of $66.19.